Ultragenyx $122 million IPO explodes, doubling price in first few hours of trading

Rare disease drug developer Ultragenyx Pharmaceutical Inc. exploded onto the market Friday, setting its IPO price at $21 but climbing to just short of $48 per share by mid-day trading...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.